Capa, Estelito .
HRN: 06-89-29 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/09/2022
CEFUROXIME 1.5GM (VIAL)
10/09/2022
10/16/2022
IV
1.5 G
Q8H
Multiple Abrasions, Lacerated Wound Inferior Lip Secondary To VA
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes